Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. A. Schiff
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer
HPB
Hepatology
Gastroenterology
Hypermethylated Epidermal Growth Factor Receptor (EGFR) Promoter Is Associated With Gastric Cancer
Scientific Reports
Multidisciplinary
BRAF; Epidermal Growth Factor Receptor (EGFR)
Science-Business eXchange
miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression
Cancer Research
Cancer Research
Oncology
AXL/epidermal Growth Factor Receptor (EGFR) Complexes in Breast Cancer - Culprits for Resistance to EGFR Inhibitors?
Breast Cancer Research
Cancer Research
Oncology
The Association Between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk
Biomolecules
Biochemistry
Molecular Biology
Unusual Manifestation of Anaplastic Thyroid Cancer
Acta medica (Hradec Kralove)
Medicine
OA14 Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Epidermal Growth Factor Receptor-Targeted Photosensitizer Selectively Inhibits EGFR Signaling and Induces Targeted Phototoxicity in Ovarian Cancer Cells
Cancer Letters
Cancer Research
Oncology
